アジェンダ

Day 1 2024年10月27日 (日)

9:30 AM — 1:00 PM

Student Session : The Safety Management of Medicines in the Post-Marketing Phase

10:00 AM — 12:00 PM

Patient Driven Session : Cancer Salon at Tokyo Big Sight ~Cancer Chat Cafe in DIA Japan Annual Meeting 2024~

1:30 PM — 2:00 PM

Orientation

2:00 PM — 2:30 PM

Opening

2:45 PM — 3:45 PM

Program Chair Session : Toward a Well-Being Future in which Each and Every One of Us Has ‘Ikigai’

4:15 PM — 5:15 PM

Keynote Address : Clinical Application of Human iPS Cells -To Perform ikigai with Healthy Condition-

6:00 PM — 8:00 PM

Networking Session

Day 2 2024年10月28日 (月)

9:30 AM — 11:00 AM

S01 : Clinical Development Strategy in Light of the New Guidance for Japanese Phase 1 Study before Participating in MRCTs

9:30 AM — 11:00 AM

S02 : Capability Development for Next-Generation Data Managers as a Critical Realm of Profession in Clinical Development (CDM)

9:30 AM — 11:00 AM

S03 : Paradigm Shift from Disease Treatment to Prevention and Health Care

9:30 AM — 11:00 AM

S04 : The Approach and Expectations for PMDA Review Reports as Drug Information (MC)

9:30 AM — 10:30 AM

S05 : Breaking Away from Complex Protocols - Protocol Simplification -

9:30 AM — 11:00 AM

S06 : The Future of Japan in Diversifying Global Drug Development

10:00 AM — 1:00 PM

#SC01: (Bioethics) Patient Experience Data (PED) - Its Values and Use

10:45 AM — 11:45 AM

S07 : The Clue of the New Drug Development for Rare Diseases Created by One Team; industry, Academia, Government and Patients

11:30 AM — 1:00 PM

S09 : What should the NHI Drug Pricing System be to Enhance the Attractiveness of the Japanese Pharmaceutical Industry, and What Data Show Its True Value? (HEOR+)

11:30 AM — 1:00 PM

S10 : What is your "IKIGAI"? Let's think from illness

11:30 AM — 1:00 PM

S11 : Exploring Complex Innovative Trial Designs: Application of the Estimand Framework and Case Studies (Stat)

11:30 AM — 1:00 PM

S13 : The Potential for Electronic Labeling Based on Database Investigation - Aiming to Provide Valuable Information!

11:30 AM — 1:00 PM

Special Session - 1 : Promotion of Pediatric Drug Development - Current Situation and Future Prospects -

12:00 PM — 1:00 PM

S12 : Promoting Diversity in Patient & Public Involvement (PPI) - Voices of Diverse Patients in Clinical Trials (PEC)

2:30 PM — 4:00 PM

S15 : How ICH E17 Enables East Asian Countries to Change Their Development Strategies in Simultaneous Development?

2:30 PM — 4:00 PM

S16 : The Role of Academia in Protocol Development for Corporate Clinical Trials

2:30 PM — 4:00 PM

S17 : What Do We Need for EHR-EDC in HL7 FHIR to Move Forward

2:30 PM — 4:00 PM

S18 : Challenge of DX for the Clinical Trial Ecosystem: Utilization of Clinical Protocol Data

2:30 PM — 4:00 PM

S19 : From Ikigai to Well-being - Let’s Dialogue about the Future of Clinical Development with Academia, Government, Industry, and Public - Academia PM Cafe Spin-Off in DIA Japan Annual Meeting

2:30 PM — 4:00 PM

Special Session - 2 : China Hospital Session - Update on Clinical Development in China -

3:00 PM — 6:00 PM

#SC02: (LCM) Maximizing the Practical Use of Medical Information Databases ~Let’s Have a Hot Discussion on Effective Utilization Among Companies, Authorities, and Academia~

4:30 PM — 6:00 PM

S21 : Recommendations for Plain Language Summary to Promote Mutual Understanding

4:30 PM — 6:00 PM

S22 : Implementation of QbD and IQRMP for Clinical Trials to Enhance Field Capability ~ Social Co-Creation Process Guided by Dialogue ~

4:30 PM — 6:00 PM

S23 : The Forefront of RPA/AI Use in Pharmacovigilance (PV)

4:30 PM — 6:00 PM

S24 : The New Wave Pioneered by Digital Technology: Approaching Unmet Medical Needs with a Patient-Centricity (MA)

4:30 PM — 6:00 PM

S25 : Let's Talk about the Meaning of "Society, "R&D," and "I." - AMED Social Co-Creation EXPO - in DIA -

4:30 PM — 6:00 PM

Special Session - 3 : Promoting Utilization of Reliance in Assessment by ASEAN

6:15 PM — 8:15 PM

Special Chatting Session : Let’s Chat! “What’s the DIA World 2024”

Day 3 2024年10月29日 (火)

9:30 AM — 11:00 AM

DIAmond Session - 1 : Future Design

9:30 AM — 11:00 AM

S27 : Preventing Misconduct Recurrence - Implementing Detection Mechanisms and Fostering an Environment that Deters Misconduct

9:30 AM — 11:00 AM

S28 : The Ideal State of Clinical Trials in Japan and the Creation of a Clinical Trial Ecosystem through the Implementation of DCT in the Oncology Field

9:30 AM — 11:00 AM

S29 : Updating Regulatory Documents through the Use of Digital Technology and Implementation of New Platforms

9:30 AM — 11:00 AM

S30 : Now and Future of Digital Utilization for Patient Pharmaceutical Information: Initiatives in Western Countries and Future Approaches in Japan

9:30 AM — 11:00 AM

S31 : Introduction to Coaching: Discovering Ikigai (Student OBOG)

10:00 AM — 1:00 PM

#SC03: (Patient Engagement) Aiming for Clinical Trials That Satisfy Participants: Thinking Together with All Stakeholders About Actions for Satisfaction

11:30 AM — 1:00 PM

S32 : To Promote Patient and Public Involvement in Drug Discovery in the Field of Neirological Diseases

11:30 AM — 1:00 PM

S33 : Current Status and Issues of Pharmaceutical Venture Support Based on Efforts to Improve Pharmaceutical Regulations (RA)

11:30 AM — 1:00 PM

S34 : How does Clinical Development Change with Health Data in Digital World? #Digital Health #Generation of Synthetic Patient Data #Clinical Prediction Model (CI)

11:30 AM — 1:00 PM

S35 : Modeling & Simulation - Potential Challenges for Breakthrough in Current Drug Loss/Lag State (CP)

11:30 AM — 1:00 PM

S36 : Promoting a "Clinical Trial Ecosystem" as ALL Japan

11:30 AM — 1:00 PM

S37 : Facing the Reality of Healthcare, How do We Live? (PM)

3:00 PM — 4:30 PM

DIAmond Session - 2 : China Townhall

3:00 PM — 4:30 PM

S39 : Innovative Thinking to Optimize Drug Development for Rare Diseases - Ideas for Efficacy Evaluation and Strategies for Utilizing RWD -

3:00 PM — 4:30 PM

S40 : Toward the Better Timing and Necessary Measures to Initiate Pediatric Drug Development: For the Well-being of Pediatric Patients

3:00 PM — 4:30 PM

S41 : Toward Advancing Risk Communication in Pregnancy through Data Collection and Utilization

3:00 PM — 4:30 PM

S42 : Taking on the Challenge of Operational Transformation in Clinical Trial (COM)

3:00 PM — 4:30 PM

S43 : Creation and Provision of Pharmaceutical Product Information Considering Health Literacy

3:30 PM — 6:30 PM

#SC04: (MA) Challenge to Visualize Our Impact! Strategies to Improve Patient Outcomes in the Healthcare Industry

5:00 PM — 6:30 PM

DIAmond Session - 3 : DIA Townhall

5:00 PM — 6:30 PM

S45 : Are You Ready for the GCP Renovation Initiative?

5:00 PM — 6:30 PM

S46 : Development of New Drugs / Medical Devices with "Public Mind" : The Expected Roles of Industry (Private Sector) & Agency (Public Sector) and its Balance

5:00 PM — 6:30 PM

S47 : Choosing to Work in Start-ups: Talent Mobility and Promotion of Open Innovation in Japanese Pharmaceutical Industry (OI)

5:00 PM — 6:30 PM

S48 : Digital Apps Change Healthcare - Toward the Creation of "Ikigai" - (Device)

5:00 PM — 6:30 PM

S49 : Career Development with Ornership! - For a Future Filled with Well-being - (OT)

6:45 PM — 7:15 PM

Closing

The 21st DIA Japan Annual Meeting 2024

アジェンダ

最新情報や機会を逃さないで